CRISPR technique may lead to hypoallergenic cats April 7, 2022 -- Love cats but have allergies? Rejoice! Scientists have demonstrated that CRISPR gene editing of the cat allergen, Felis domesticus allergen I, could bring relief to those with cat allergies, according to a proof-of-concept study published online in the CRISPR Journal.Read More
Bruker acquires Optimal companies for pharma software, technologies April 6, 2022 -- Bruker has acquired biopharma solutions provider Optimal Industrial Automation and Technologies. The company said that the acquisition will strengthen it as a key software and solutions provider for small molecule, biologics, and new drug modalities pharma companies.Read More
Getting to know the Association of Biomolecular Resource Facilities (ABRF) May 4, 2023 -- The Association of Biomolecular Resource Facilities (ABRF) will hold its Annual Meeting May 7 to May 10 in Boston. ABRF is a membership organization that brings together Core facilities across the U.S. and supports more than 2,400 members at over 400 institutions including organizations in government, academia, research, industry, and commercial settings. Over 50% of its members define their area of professional responsibility as either genomics or core administration.Read More
Gene variant map helps diagnose hereditary diabetes May 4, 2023 -- University of Copenhagen researchers are using high-throughput experiments to explore connections between inherited diseases and a specific gene called GCK. The study, published April 26 in Genome Biology, may help provide better diagnoses of hereditary diabetes and other diseases.Read More
Meeting on the Mesa comes at pivotal time for cell and gene therapy industry October 5, 2022 -- Stakeholders from around the cell and gene therapy sector will come together during the Alliance for Regenerative Medicine’s hybrid 2022 Meeting on the Mesa, October 11-13 in Carlsbad, CA, to discuss the opportunities and challenges facing the industry.Read More
FDA creates “Super Office” to manage growing cell and gene therapy workload October 4, 2022 -- The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies to a “Super Office” within the Center of Biologics Research and Evaluation to meet its growing cell and gene therapy workload.Read More
Rogue killer T cells contribute to autoimmunity: study November 29, 2022 -- Scientists from the Garvan Institute of Medical Research have found new insight into the role that killer T cells play in leukemia and autoimmune disease. They contend that their findings could be helpful in narrowing down pathways to target these cells for future treatments.Read More
Scientists offer way to overcome barriers to nucleic acid delivery November 23, 2022 -- Scientists from Australia's Monash University have suggested ways of overcoming the challenges in delivering nucleic acid therapeutics, including engineering smart, responsive, and targeted nanoparticle delivery systems.Read More
Antiviral-antibody combination improves influenza outcomes in mice August 17, 2022 -- Researchers at McMaster University found in a mouse study that combining a class of well-known antiviral drugs and neutralizing antibodies was more effective than either approach alone, which they contend could be used to treat seasonal influenza and help prevent the next flu pandemic.Read More
Protein tail mutation may cause rare genetic diseases February 13, 2023 -- Researchers from Germany found that a change in a protein’s charge disrupts cellular self-organization, resulting in an extremely rare hereditary developmental disorder called brachyphalangy-polydactyly-tibial aplasia/hypoplasia syndrome (BPTAS).Read More
MicroRNAs strongly associated with type 2 diabetes in study February 10, 2023 -- Scientists at the NIH’s National Human Genome Research Institute (NHGRI) have found a set of small RNA molecules, called microRNAs, in human pancreatic cells that are strongly associated with type 2 diabetes.Read More
Zebrafish help scientists understand organ regeneration September 20, 2022 -- Researchers from the Stowers Institute for Medical Research are using zebrafish to investigate how their immune systems repair and regenerate organs. The findings could potentially help alleviate human conditions that might otherwise require organ transplants and lifelong immunosuppressants.Read More
Video from AACC: Thermo Fisher CMO on the future of diagnostics July 28, 2022 -- Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's sister site LabPulse.com to discuss shifts in the diagnostic testing landscape.Read More
AIDS 2022 research sheds new light on HIV cells July 28, 2022 -- New research presented at the AIDS 2022 conference shows the HIV-infected memory CD4+ T-cell reservoir is a distinctive cell population that may be uniquely susceptible to specific targeted therapies.Read More